Purpose
to advance O-antigen-based Shigella vaccines through to licensure by providing the critical data on immunogenicity linked to efficacy required for immunobridging
Grantee
Division
Global Health
Date
JUNE 2018
Region served
GLOBAL
Committed amount
$48,647
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
24
Grantee location
London, United Kingdom
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.